Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 5/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 5/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5830558 | 0.95 | KDM4A (0.37) | DNM1GAAKDM4ESMN1; SMN2ALDH1A1 | |
| Bromide SCHEMBL1061717 | 0.86 | KDM4A (0.39) | DNM1TSHRKDM4ESMN1; SMN2ALDH1A1 | |
| Methacrylic Acid SCHEMBL1627466 | 0.86 | CHRM1 (0.41) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| Bromide SCHEMBL7779909 | 0.84 | TSHR (0.54) | DNM1TSHR | |
| SCHEMBL666460 | 0.84 | TSHR (0.42) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL22599 | 0.84 | KDM4A (0.40) | DNM1TSHRKDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL7502000 | 0.84 | KDM4A (0.40) | DNM1TSHRKDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL4162830 | 0.84 | TSHR (0.54) | DNM1GAATSHRKDM4ESMN1; SMN2 | |
| SCHEMBL8736372 | 0.83 | CHRM2 (0.36) | DNM1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL28015079 | 0.83 | DNM1 (0.44) | DNM1GAACHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7041338-B2 | Process for providing a coated paper, a resin coated paper, a polymeric film, and a flexible or inflexible woven fabric substrate by utilizing a coating composition containing a nitrogenous dye-fixing compound | PIXTERRA, INC. (US) | 2006-05-09 | — | — | US | claimed |
| US-20030219539-A1 | Coating compositions, process for making coating compositions, method for providing a water-resistant image on a substrate using an ink-jet printer and printed substrate thereof | PIXTERRA INC | 2003-11-27 | — | — | US | claimed |
| WO-2003092913-A1 | INK-JET COATING COMPOSITIONS, PROCESS FOR MAKING, AND USE IN PROVIDING WATER-RESISTANT IMAGE | PIXTERRA, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| US-20100239673-A1 | Blood compatible nanomaterials and methods of making and using the same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-09-23 | — | — | US | disclosed |
| WO-2008045021-A2 | BLOOD COMPATIBLE NANOMATERIALS AND METHODS OF MAKING AND USING THE SAME | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2008-04-17 | — | — | WO | disclosed |
| US-7041338-B2 | Process for providing a coated paper, a resin coated paper, a polymeric film, and a flexible or inflexible woven fabric substrate by utilizing a coating composition containing a nitrogenous dye-fixing compound | PIXTERRA, INC. (US) | 2006-05-09 | — | — | US | disclosed |
| US-20040202832-A1 | Ink-jet recording medium with at least two layers coated upon a substrate, method for recording a water-resistant image on the medium using an ink-jet printer and the recorded medium thereof | PIXTERRA, INC. | 2004-10-14 | — | — | US | disclosed |
| WO-2004005039-A1 | INK-JET RECORDING MEDIUM, METHOD FOR RECORDING A WATER-RESISTANT IMAGE ON THE MEDIUM AND THE RECORDED MEDIUM | PIXTERRA, INC. (US) | 2004-01-15 | — | — | WO | disclosed |
| US-20030219539-A1 | Coating compositions, process for making coating compositions, method for providing a water-resistant image on a substrate using an ink-jet printer and printed substrate thereof | PIXTERRA INC | 2003-11-27 | — | — | US | disclosed |
| WO-2003092913-A1 | INK-JET COATING COMPOSITIONS, PROCESS FOR MAKING, AND USE IN PROVIDING WATER-RESISTANT IMAGE | PIXTERRA, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239673-A1 | Blood compatible nanomaterials and methods of making and using the same | MB, ICAM1, F3 | DNM1 4793/4885GAA 3846/4885CHRM2 4678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.